GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beam Therapeutics Inc (MEX:BEAM) » Definitions » Float Percentage Of Total Shares Outstanding

Beam Therapeutics (MEX:BEAM) Float Percentage Of Total Shares Outstanding : 76.32% (As of May. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Beam Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Beam Therapeutics's float shares is 62.82 Mil. Beam Therapeutics's total shares outstanding is 82.31 Mil. Beam Therapeutics's float percentage of total shares outstanding is 76.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Beam Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Beam Therapeutics's Institutional Ownership is 61.15%.

Beam Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Beam Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=62.82/82.31
=76.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beam Therapeutics (MEX:BEAM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beam Therapeutics Inc (MEX:BEAM) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
VCYT PTCT SWTX IDYA VCEL ACLX RCKT NMRA SMMT PNT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BEAM:USA
Address
238 Main Street, Cambridge, MA, USA, 02142
Website
https://www.beamtx.com
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.